THE DETAIL TO KEEP
Separate clinical and consumer footnotes; no full independent appraisal or injectable equivalence established.
Sections in this fieldnote
Medik8 Liquid Peptides Advanced MP makes several kinds of promises on one page: a quick change in the appearance of expression lines, a longer-term wrinkle claim, and an advanced peptide story. Reading them as a single result would make the offer sound simpler than it is. This review separates the formula description from the measurements used to promote it.
The US manufacturer record checked October 5, 2026 lists a 30 mL serum at $95. That is an observed product-page price, not a completed order. Our interest is in what a reader can establish before buying: which copper ingredient is named, what the large percentage covers, and which questions remain after reading the study footnotes.
Start with the full product name
Advanced MP is the specific serum in this file. A discussion of another Medik8 peptide product should not be treated as its ingredient declaration or evidence record. Photograph the current package name if comparing an older bottle with a new listing. A change in a suffix or formula can matter even when a brand's overall positioning remains familiar.
The checked declaration names Copper Palmitoyl Heptapeptide-14. That is a more useful identifier than the broad phrase copper peptides. It belongs alongside the complete ingredient list and its date, rather than being replaced with GHK-Cu because that name appears frequently in other reviews. The ingredient-name fieldnote explains this comparison problem.
The large number describes a complex
Medik8 advertises a 30% multi-peptide complex and a collection of 13 peptides. Neither statement establishes 30% copper peptide in the finished serum. A complex can include multiple components; a count of peptides is a count of named participants, not a measurement of each participant's amount or contribution.
This distinction becomes especially important next to NIOD's ratio-based description. Two percentages can look comparable in a shopping table while describing different things. If a seller cannot identify the basis of a number, leave that field unresolved instead of converting it into an apparent strength advantage. The comparison should preserve the uncertainty the source leaves behind.
Keep the time points apart
The manufacturer attaches its claims to several study summaries. These include clinical groups of 34 and 20 participants and consumer groups with different sizes and selection criteria. The complete reports were not independently appraised for this publication. A footnote provides useful context, but it is not the same as having enough methodological detail to judge the whole study.
A ten-minute appearance observation and an eight-week result answer different questions. So does a participant's opinion compared with an instrumental measurement. Ask which endpoint supports the sentence you care about, what the comparison was, and whether the effect persisted. Our human-evidence guide offers a way to keep those questions visible without turning every marketing footnote into a clinical conclusion.
Injection-related wording needs a boundary
The page positions the serum alongside injectable cosmetic treatments. That language does not establish that a topical serum produces the same outcome as an injection, reduces the need for a procedure, or is appropriate immediately after one. A group of people who previously had injectables is not automatically a head-to-head trial against an injectable treatment.
If your interest comes from a recent procedure, use the treating clinician's instructions. The microneedling fieldnote explains why a routine cosmetic comparison does not supply aftercare approval. The relevant detail is the actual procedure and recovery plan, not whether the serum's name sounds technologically advanced.
Consider the bottle as one routine step
The serum's base contains ingredients beyond its peptides. Reading the whole formula is more useful than imagining the copper component acting alone. We have not tested spread, finish, comfort, or compatibility with a particular sunscreen. The brand's texture description remains the brand's description, even when it sounds appealing.
A reader already using several treatment serums can ask what role this one would replace or add. That is different from building the largest possible routine. The cream-versus-serum discussion helps organize the format question, while the current package should remain the reference for product-specific directions.
Keep the offer separate from the evidence
The observed $95 is for the selected 30 mL US product. Bundles, loyalty rewards, promotions, and shipping thresholds may change the checkout total. A notification panel and a purchase button can also coexist in retrieved page content, so this review does not promise immediate stock or delivery. Confirm the selected variant directly before ordering.
To compare buying routes, open the CoreAge cream file beside this retail serum record. The comparison is useful precisely because a provider-guided offer and a retail bottle involve different questions. Preserve the product identity, invoice unit, and evidence limit in a pocket fieldnote, then decide whether the available information answers your own purchasing question.
SOURCE NOTES
What this record draws on
- Medik8 — Liquid Peptides Advanced MP ↗
Copper Palmitoyl Heptapeptide-14; 30% refers to a multi-peptide complex, not a copper concentration. US 30 mL displayed $95 on October 5; selected availability and final checkout need confirmation. Separate clinical and consumer footnotes; no full independent appraisal or injectable equivalence established. Accessed 2026-10-05.
- FDA — Cosmetics Labeling Guide ↗
General ingredient-order rules, including the 1% or less exception and separate color-additive provisions. Not a determination about any particular product. Accessed 2026-09-26.
- FDA — Cosmetic, drug, or both? ↗
Explains intended use, product claims and the distinction between cosmetics and drugs. No separate legal category for cosmeceuticals. Accessed 2026-09-25.
Individual source access dates are recorded above. Prices, stock, labels, and directions can change. How we review.